Sex-differences from referral to tafamidis treatment outcomes in real-world patients with wild-type transthyretin amyloid cardiomyopathy.

Back

HFA Premium Access

Sex-differences from referral to tafamidis treatment outcomes in real-world patients with wild-type transthyretin amyloid cardiomyopathy.

Session: Evaluation of prognosis in cardiomyopathies

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor P. Debonnaire (Brugge, BE)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Philippe Debonnaire

AZ Sint Jan, Brugge (Belgium)

7 presentations

6 followers

4 more presentations in this session

Prevalence and prognostic implications of right ventricular systolic dysfunction and reverse remodeling in dilated cardiomyopathy: a longitudinal prospective cardiac magnetic resonance investigation

Speaker: Doctor E. Dziewiecka (Krakow, PL)

Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy

Speaker: Doctor M. Setti (Verona, IT)

Exercise intensity and cardiac disease development in carriers of titin variants

Speaker: Doctor G. Savonitto (Trieste, IT)

Cardiac magnetic resonance and genetics: an integrated approach to predict left ventricular reverse remodeling in dilated cardiomyopathy

Speaker: Doctor M. Iseppi (Trento, IT)

Access the full session

Evaluation of prognosis in cardiomyopathies

Speakers: Doctor P. Debonnaire, Doctor E. Dziewiecka, Doctor M. Setti, Doctor G. Savonitto, Doctor M. Iseppi

Access

Video

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources